Related Experiment Videos
Müllerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes
E A Catlin1, N D Uitvlugt, P K Donahoe
1Pediatric Surgical Research Laboratory, Massachusetts General Hospital, Boston 02114.
Abstract:
Neonatal males develop respiratory distress syndrome more frequently than females for unknown reasons. The fetal testis secretes testosterone and müllerian inhibiting substance (MIS); MIS has been shown to inhibit fetal lung maturation in vitro and in vivo and to block phosphorylation of epidermal growth factor (EGF) receptors in A431 cells. We hypothesized that MIS would also inhibit membrane phosphorylation of EGF receptors in fetal lung, and that ultrastructural study of MIS-exposed lung might complement the biochemical data by assessing the effect of MIS on tissue morphology. Lung membranes were prepared from 19.5-day fetal rats and phosphorylation assays performed with 3 to 4 micrograms of membrane protein, with or without EGF (26 nmol/L), 0.025 mCi AT32P (0.136 mumol/L), and either recombinant human MIS (rhMIS, 30 pmol) from media of Chinese hamster ovary (CHO) cells, rhMIS dialysis buffer, or wild-type CHO media. The 170,000 molecular weight EGF receptor, visualized by autoradiography of polyacrylamide gels, was phosphorylated in both female and male membranes. rhMIS, when added to EGF-stimulated membranes, caused significant inhibition of EGF receptor phosphorylation (females: 32.42% +/- 11.5%; males: 32.3% +/- 19.1%, P less than 0.001; rhMIS-treated v EGF-stimulated state, P = NS, male v female, Cerenkov counting). Electron microscopy (EM) of rhMIS-exposed lung showed decreased lamellar bodies (LB) in both male alveolar spaces and female parenchyma, and, unexpectedly, increased numbers in female alveoli. Immunoabsorption experiments using coincubation of rhMIS with anti-rhMIS IgG polyclonal antibodies or equiprotein normal IgG demonstrated MIS antibody-specific reversal of rhMIS activity in membrane phosphorylation.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Müllerian inhibiting substance (MIS) inhibits epidermal growth factor (EGF) receptor phosphorylation in fetal rat lungs, potentially explaining why males develop respiratory distress syndrome more often than females.
Area of Science:
- Reproductive Endocrinology
- Developmental Biology
- Pulmonary Medicine
Background:
- Neonatal males exhibit higher rates of respiratory distress syndrome (RDS) compared to females.
- Fetal testes produce Müllerian inhibiting substance (MIS), which impacts fetal lung maturation.
- MIS has been shown to inhibit epidermal growth factor (EGF) receptor phosphorylation in vitro.
Purpose of the Study:
- To investigate the effect of MIS on EGF receptor phosphorylation in fetal rat lung membranes.
- To assess the impact of MIS on fetal lung morphology using electron microscopy.
Main Methods:
- Fetal rat lung membranes were isolated and subjected to phosphorylation assays with EGF and recombinant human MIS (rhMIS).
- EGF receptor phosphorylation was quantified using autoradiography and Cerenkov counting.
- Lung tissue ultrastructure was examined via electron microscopy following rhMIS exposure.
- Antibody-mediated neutralization of rhMIS was used to confirm specificity.
Main Results:
- rhMIS significantly inhibited EGF receptor phosphorylation in both male and female fetal rat lung membranes.
- Electron microscopy revealed decreased lamellar bodies in rhMIS-exposed lungs, with an unexpected increase in female alveoli.
- MIS antibody reversed the inhibitory effect of rhMIS on receptor phosphorylation, confirming specificity.
Conclusions:
- MIS inhibits EGF receptor phosphorylation in fetal lung tissue.
- MIS may play a role in the sex-based disparity of neonatal respiratory distress syndrome.
- Further research is warranted to elucidate the precise mechanisms and clinical implications.